References

1. Handbook of Pharmacokinetic/Pharmacodynamic Correlation. H. Derendorf and G. Hochhaus eds. CRC Press Inc. Boca Raton, FL, 1995.

2. Casarett and Doull's Toxicology The Basic Science of Poisons. M.O. Amdur, J. Doull and C.D. Klaassen, eds. Pergamon Press, Inc., Elmsford, NY, 1991.

3. Goodman & Gilman's The Pharmacological Basis of Therapeutics, J.G. Hardman and L.E. Limbird, eds.-in -chief. McCraw-Hill Companies, Inc., NY, NY, 1996.

4. Benz, R., Janko, K., and Langer, P.: Pore formation by the matrix protein (porin) to Escherichia coli in planar bilayer membranes. Ann. N.Y. Acad. Sci. 358:13-24, 1980.

5. Sobel, A.E., Gawron, O., and Kramer, B.: Influence of vitamin D in experimental lead poisoning. Proc. Soc. Exp. Biol. Med. 38: 433-435, 1938.

6. Bates, T.R., and Gibaldi, M.: Gastrointestinal absorption of drugs. In Swarbuck, J. ed.: Current concepts in the pharmaceutical sciences: biopharmaceutics. Lea & Febiger, Philadelphia, PA, 1970.

7. R. C. Baselt, and R.H. Cravey. Disposition of Toxic Drugs and Chemicals in Man. Chemical Toxicology Institute, Foster City, CA, 1995.

8. Kupferberg, H.J., and Way, E.L.: Pharmacologic basis for the increased sensitivity of the newborn rat to morphine. J. Pharmacol. Exp. Ther. 141: 105-112,1963.

9. Principles of Drug Action The Basis of Pharmacology. W.B. Pratt and P. Taylor eds. Churchill Livingstone Inc., New York, NY, 1990.

10. Sulfation ofDrugs and Related Compounds, Mulder, G.J., ed. CRC Press, Inc., Boca Raton, FL, 1981.

11. Hepatic cytochromeP-450 monooxygenasesystem. Schenkman, J.B. and Kupfer, D., eds. Pergamon Press, Oxford, England, 1982.

12. Gonzalez, F.J.: The molecular biology of cytochrome P450s. Pharmacol. Rev. 40: 243, 1988.

13. Conney, A.H.: Induction of microsomal cytochrome P-450 enzymes. Life Sci. 39:2493, 1986.

14. Stowe, C.M., and Plaa, G.L.: Extrarenal excretion of drugs and chemicals, Annu. Rev. Pharmacol. 8:337-356, 1968.

15. Weiner, I.M., and Mudge, G.H.: Renal tubular mechanisms for excretion of organic acids and bases. Am. J. Med. 36:743-762, 1964.

16. Clinical Pharmacokinetics Concepts and Applications, Rowland, M. and Tozer, T.N., Lea & Febiger, Philadelphia, PA, 1989.

17. Hagan, R.L. : Basic Pharmacokinetics. In-Service Training and Continuing Education AACC/ TDM, American Association for Clinical Chemistry, Inc., Washington, D.C. 17 (9): 231-247 (1996).

18. Ellenhorn, M.J., and Barceloux, D.G.: Medical toxicology, diagnosis and treatment of human poisoning. New York: Elsevier (1988).

19. Harris, R.Z., Benet, L.Z., and Schwartz, J.B.: Gender effects in pharmacokinetics and pharmacodynamics. Drugs 50 (2): 222-239 (1995).

20. Greenblatt, D.J., Allen, M.D., Harmatz, J.S.: Diazepam disposition determinants. Clin. Pharmacol. Ther. 27:301-312 (1980).

21. Greenblatt, D.J., Divoll, M., and Harmatz, J.S.: Oxazepam kinetics: effects of age and sex. J. Pharmacol. Exp. Ther. 215:86-91 (1980).

22. Greenblatt, D.J., Divoll, M., and Abernathy, D.R.: Age and gender effects on chlordiazepoxide kinetics: relation to antipyrine disposition. Pharmacology 38: 327-334 (1989).

23. Relling, M.V., Lin, J.S., and Ayers, G.D.: Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities. Clin. Pharmacol. Ther. 52: 643-658 (1992).

24. Routledge, P.A., Stargel, W.W., and Kitchell, B.B.: Sex-related differences in the plasma protein binding of lignocaine and diazepam. Br. J. Clin. Pharmacol. 11:245-250 (1981).

25. Wilson, K.: Sex-related differences in drug disposition in man. Clin. Pharmacokinet. 9: 189-202 (1984).

26. Yonkers, K.A., Kando, J.C., and Cole, J.O.: Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication. Am. J. Pyschiatry 149:587-595 (1992).

27. Knight, V., Yu, C.P., and Gilbert, B.E.: Estimating the dosage of ribavirin aerosol according to age and other variables. J. Infect. Dis. 158: 443-447 (1988).

Was this article helpful?

0 0

Post a comment